Analytical Profiling of Biosynthetic Intermediates Involved in the Gentamicin Pathway ofMicromonospora echinosporaby High-Performance Liquid Chromatography Using Electrospray Ionization Mass Spectrometric Detection
- 24 May 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 79 (13) , 4860-4869
Abstract
In the present study, we developed a sensitive and highly selective method of detecting the biosynthetic intermediates involved in the gentamicin pathway from a cell culture of Micromonospora echinospora. A novel extraction method utilizing a dual solid-phase extraction (SPE) technique was employed to purify and recover all of the gentamicin-related components from the cell culture broth, and high-performance liquid chromatography (HPLC) coupled with electrospray ionization mass spectrometry (ESI-MS/MS) was used to analyze the extractant for gentamicin intermediates. The pH of the culture broth was adjusted to an acidic condition of pH 2 prior to the extraction. The samples were first cleaned with a reversed-phase AccuBOND C18 cartridge, and then the aminoglycosidic components were purified using a cationic exchanger OASIS MCX cartridge. The detection limit of a gentamicin standard spiked in blank medium processed by this method was found to be approximately 5 ng for each component of the gentamicin C complex, and the mean recovery for each component of standard gentamicin was above 91% when analyzed by HPLC-ESI-MS/MS. We further demonstrated that this method enables the analytical profiling of the gentamicin-related compounds produced by wild-type M. echinospora ATCC 15835, which mainly produces the gentamicin C complex, and the UV-induced mutant strain KCTC 10506BP, which produces gentamicin B as the major product. Seven intermediates (paromamine, gentamicin A2, B, X2, A, JI-20A, and JI-20B) besides the gentamicin C complex were detected in the culture broth of both M. echinospora strains when analyzed by MS/MS for the distinct fragmentation patterns of each gentamicin component. This report displays the first example of the HPLC profiling in a wide range of structurally related biosynthetic intermediates involved in the gentamicin pathway.Keywords
This publication has 23 references indexed in Scilit:
- Gentamicin assay in human serum by solid-phase extraction and capillary electrophoresisElectrophoresis, 2005
- Hydrophilic interaction chromatography combined with tandem-mass spectrometry to determine six aminoglycosides in serumJournal of Chromatography A, 2004
- Aminoglycoside−Arginine Conjugates That Bind TAR RNA: Synthesis, Characterization, and Antiviral ActivityBiochemistry, 2000
- Analysis of gentamicin sulfate by high-performance liquid chromatography combined with thermospray mass spectrometryJournal of Chromatography A, 1991
- Aminoglycoside research 1975-1985: prospects for development of improved agentsAntimicrobial Agents and Chemotherapy, 1986
- Use of perfluorinated carboxylic acids in the separation of aminoglycoside antibiotics by ion-pair reversed-phase high-performance liquid chromatographyJournal of Chromatography A, 1984
- Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycinAntimicrobial Agents and Chemotherapy, 1980
- Binding of Gentamicin and Other Aminoglycoside Antibiotics to Mycelium of Various ActinomycetesAntimicrobial Agents and Chemotherapy, 1973
- Chromatographic separation of the components of the gentamicin complexJournal of Chromatography A, 1968
- The separatin and differentiation of the gentamicin complexJournal of Chromatography A, 1967